Anzeige
Mehr »
Login
Freitag, 15.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Investment in die Zukunft: Absoluter Geheimtipp - diese Aktie beschleunigt deine Renditechancen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E17K | ISIN: US6412558800 | Ticker-Symbol: NLZ0
NASDAQ
14.11.24
17:41 Uhr
3,780 US-Dollar
+0,190
+5,29 %
1-Jahres-Chart
NEUROMETRIX INC Chart 1 Jahr
5-Tage-Chart
NEUROMETRIX INC 5-Tage-Chart

Aktuelle News zur NEUROMETRIX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.11.NeuroMetrix, Inc. - 10-Q, Quarterly Report-
05.11.NeuroMetrix, Inc. - 8-K, Current Report-
NEUROMETRIX Aktie jetzt für 0€ handeln
01.11.NeuroMetrix stock touches 52-week high at $4.732
01.11.NeuroMetrix-Aktie erreicht 52-Wochen-Hoch bei 4,73 US-Dollar2
13.08.NeuroMetrix continues strategic review to boost value1
13.08.NeuroMetrix, Inc.: NeuroMetrix Reiterates its Review of Strategic Alternatives146WOBURN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today for the purpose of clarity, reiterated that the Company is engaged in a review of strategic alternatives. In...
► Artikel lesen
13.08.NeuroMetrix stock plunges to 52-week low of $2.661
06.08.NeuroMetrix, Inc. - 10-Q, Quarterly Report-
06.08.NeuroMetrix, Inc. - 8-K, Current Report1
31.07.NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call1
21.05.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.05.20242.468The following instruments on Boerse Frankfurt do have their last trading day on 21.05.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.05.2024.ISIN NameCA00379L1067 ABRASILV....
► Artikel lesen
19.04.NeuroMetrix, Inc.: NeuroMetrix Announces Steps Taken to Enhance Shareholder Value464Joshua S. Horowitz joins Board of DirectorsAt-the-market equity facility terminated WOBURN, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced two steps to...
► Artikel lesen
13.03.NeuroMetrix, Inc.: NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell Fibromyalgia271WOBURN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia since its strategic...
► Artikel lesen
12.03.Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired349NURO stock price has declined 99% since its IPOGozani has received compensation of over $10 million since the IPOGozani was charged by the FTC for various wrongdoings at NUROGozani apparently personally...
► Artikel lesen
08.03.RS Fund Management LLC: RS FUND LP Calls for Immediate Action and Capital Return in Neurometrix, Inc.655Stock trades significantly below its net cash per share.The board is arguably in breach of their fiduciary responsibility to protect shareholder value. Operating any capital raise at current price is...
► Artikel lesen
04.03.Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc.346- Stock trades significantly below its net cash per share- Questions the Board's ability and/or desire to create shareholder value- Notes tremendous destruction of shareholder value under company's...
► Artikel lesen
22.02.NeuroMetrix, Inc.: NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights346WOBURN, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and full year ended December 31, 2023. The Company's...
► Artikel lesen
13.02.NeuroMetrix, Inc.: NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value297WOBURN, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a commercial stage medical device company focused on reducing the impact of neurological disorders and pain syndromes...
► Artikel lesen
12.12.23NeuroMetrix, Inc.: NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell in Post-Acute COVID-19 Syndrome (Long COVID)1.246WOBURN, Mass., Dec. 12, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) reported the recent presentation of data from a clinical trial of Quell wearable neuromodulation technology in patients...
► Artikel lesen
05.12.23NeuroMetrix, Inc.: NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)224WOBURN, Mass., Dec. 05, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted publication of results from a NIH-funded clinical trial of Quell titled "Wireless transcutaneous electric nerve...
► Artikel lesen
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1